SCHEMBL12369329

SCHEMBL12369329

COC(=O)[C@@]12C[C@@H]1/C=C\CCCCN(C)OC[C@@H]1C[C@@H](O)CN1C(=O)N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10283643 0.91 — —
SCHEMBL312570 0.83 CTSB (0.35) —
SCHEMBL8003568 0.83 CTSB (0.35) —
SCHEMBL13531204 0.77 ADRB3 (0.30) —
SCHEMBL15216165 0.75 CTSB (0.32) —
SCHEMBL10283465 0.75 CTSB (0.32) —
SCHEMBL10283470 0.75 CTSB (0.32) —
SCHEMBL7925281 0.75 ADRB3 (0.33) —
SCHEMBL10283820 0.74 CTSB (0.32) —
SCHEMBL13090638 0.72 CTSB (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003659-B2 Macrocyclic serine protease inhibitors INDENIX PHARMACEUTICALS, INC. (US) 2011-08-23 — — US disclosed
US-20090202480-A1 MACROCYCLIC SERINE PROTEASE INHIBITORS IDENIX PHARMACEUTICALS, INC. (US) 2009-08-13 — — US disclosed
Send feedback